Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Differential induction of glioblastoma migration and growth by two forms of pleiotrophin.

Lu KV, Jong KA, Kim GY, Singh J, Dia EQ, Yoshimoto K, Wang MY, Cloughesy TF, Nelson SF, Mischel PS.

J Biol Chem. 2005 Jul 22;280(29):26953-64. Epub 2005 May 20.

2.

Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.

Grzelinski M, Steinberg F, Martens T, Czubayko F, Lamszus K, Aigner A.

Neoplasia. 2009 Feb;11(2):145-56.

4.
5.

Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth.

Powers C, Aigner A, Stoica GE, McDonnell K, Wellstein A.

J Biol Chem. 2002 Apr 19;277(16):14153-8. Epub 2002 Jan 23.

7.

Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas.

Ulbricht U, Brockmann MA, Aigner A, Eckerich C, Müller S, Fillbrandt R, Westphal M, Lamszus K.

J Neuropathol Exp Neurol. 2003 Dec;62(12):1265-75.

PMID:
14692702
8.
9.

Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin.

Stoica GE, Kuo A, Aigner A, Sunitha I, Souttou B, Malerczyk C, Caughey DJ, Wen D, Karavanov A, Riegel AT, Wellstein A.

J Biol Chem. 2001 May 18;276(20):16772-9. Epub 2001 Feb 8.

10.

Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta.

Mikelis C, Sfaelou E, Koutsioumpa M, Kieffer N, Papadimitriou E.

FASEB J. 2009 May;23(5):1459-69. doi: 10.1096/fj.08-117564. Epub 2009 Jan 13.

PMID:
19141530
11.

Identification of pleiotrophin in conditioned medium secreted from neural stem cells by SELDI-TOF and SELDI-tandem mass spectrometry.

Furuta M, Shiraishi T, Okamoto H, Mineta T, Tabuchi K, Shiwa M.

Brain Res Dev Brain Res. 2004 Sep 17;152(2):189-97.

PMID:
15351507
12.
13.

Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma.

Grzelinski M, Bader N, Czubayko F, Aigner A.

Int J Cancer. 2005 Dec 20;117(6):942-51.

14.

Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase.

Bowden ET, Stoica GE, Wellstein A.

J Biol Chem. 2002 Sep 27;277(39):35862-8. Epub 2002 Jul 9.

15.

Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.

Oelmann E, Sreter L, Schuller I, Serve H, Koenigsmann M, Wiedenmann B, Oberberg D, Reufi B, Thiel E, Berdel WE.

Cancer Res. 1995 May 15;55(10):2212-9.

16.

Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.

Bouterfa HL, Sattelmeyer V, Czub S, Vordermark D, Roosen K, Tonn JC.

Anticancer Res. 2000 Jul-Aug;20(4):2761-71.

PMID:
10953355
17.

Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.

Stoica GE, Kuo A, Powers C, Bowden ET, Sale EB, Riegel AT, Wellstein A.

J Biol Chem. 2002 Sep 27;277(39):35990-8. Epub 2002 Jul 16.

18.

LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses.

Wu M, Huang C, Li X, Li X, Gan K, Chen Q, Tang Y, Tang K, Shen S, Li G.

J Cell Physiol. 2008 Jan;214(1):65-74.

PMID:
17541939
19.

Aprotinin stimulates angiogenesis and human endothelial cell migration through the growth factor pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta.

Koutsioumpa M, Hatziapostolou M, Mikelis C, Koolwijk P, Papadimitriou E.

Eur J Pharmacol. 2009 Jan 14;602(2-3):245-9. doi: 10.1016/j.ejphar.2008.11.046. Epub 2008 Dec 3.

PMID:
19059395
20.

Expression of pleiotrophin and its receptors in human placenta suggests roles in trophoblast life cycle and angiogenesis.

Ball M, Carmody M, Wynne F, Dockery P, Aigner A, Cameron I, Higgins J, Smith SD, Aplin JD, Moore T.

Placenta. 2009 Jul;30(7):649-53. doi: 10.1016/j.placenta.2009.05.001. Epub 2009 May 28.

PMID:
19481257

Supplemental Content

Support Center